Brian Park, PharmD

Drug Information Specialist https://www.dermatologyadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

General Medicine

Significant Pain Relief Observed With Intranasal Zavegepant in Migraine Trial

Brian Park, PharmD

December 13, 2021

Zavegepant is an investigational calcitonin gene-related peptide (CGRP) receptor antagonist.

Dermatitis

Rinvoq Labeling Updated to Include Class Warnings Related to JAK Inhibitors

Brian Park, PharmD

December 8, 2021

The update follows the FDA’s Drug Safety Communication, which was based on a completed review of a large randomized safety clinical trial evaluating tofacitinib in patients with rheumatoid arthritis.

General Medicine

Two-Year Data Show Significant Weight Loss With Wegovy

Brian Park, PharmD

December 6, 2021

The STEP 5 trial compared Wegovy to placebo in 304 adults who were overweight (BMI ≥27kg/m2) or obese (BMI ≥30kg/m2) over 2 years.

Psoriasis

Deucravacitinib Under Review for Moderate to Severe Plaque Psoriasis

Brian Park, PharmD

December 2, 2021

The application is supported by data from the pivotal phase 3 POETYK PSO-1 and POETYK PSO-2, which included patients with moderate to severe plaque psoriasis.